Stock Events

Stock Events

ImmuneOnco Biopharmaceuticals (Shanghai) (1541.HK) Q3 2025 Earnings

25AugConfirmed

Q3 2024

Q1 2025

Q3 2025

-0.47

-0.45

-0.43

-0.4

Details

Expected EPS

N/A

Actual EPS

-0.403373810375

Surprise EPS

-0.4

Surprise Percent

+∞%

Description

ImmuneOnco Biopharmaceuticals (Shanghai) (1541.HK) has reported earnings of -0.403373810375 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.